logo-loader

Silence Therapeutics CEO Ali Mortazavi steps down

Published: 10:46 04 Jun 2018 BST

office worker leaving office
Mortazavi has stepped down with immediate effect

Ali Mortazavi, the long-serving chief executive of Silence Therapeutics PLC (LON:SLN), is stepping down from his role with immediate effect.

Mortazavi, who had been at the helm of the RNA therapeutics specialist for six years, will be replaced temporarily by the company’s chair, Annalisa Jenkins, until a permanent successor is found.

WATCH: Silence Therapeutics 'in a hot space with few competitors'

“On behalf of the board I would like to thank Ali for his achievements and commitment to Silence over the past six years,” said Jenkins.

“Under his leadership Silence has built an experienced international executive team with significant RNAi expertise that has established a strong IP and technology platform in GalNAC-based siRNA.”

Silence shares rose 6.7% to 144p in mid-morning trade.

Chesnara reports strong 2023 results with improved cash generation and...

Chesnara PLC (LSE:CSN) chief executive Steve Murray discusses the company's full-year results for 2023 with Proactive's Stephen Gunnion, describing them as strong and particularly highlighting £53 million in commercial cash generation and a dividend coverage of around 150%. The company has...

1 hour, 46 minutes ago